Skip to main content

Uric Acid as a Predictor of In-Hospital Mortality in Acute Myocardial Infarction: A Meta-analysis

Abstract

Uric acid (UA) is generalized as a byproduct the terminal steps of purine catabolism, which are catalyzed by xanthine oxidoreductase. Xanthine oxidase activity and uric acid synthesis are reported to be increased under tissue ischemia. Therefore, elevated uric acid may act as a prognostic marker of acute myocardial infarction (AMI). A few studies have showed that UA is associated with therapeutic outcomes in patients with acute myocardial infarction. The purpose of this meta-analysis is to evaluate the prognostic significance of the UA as a predictor of in-hospital mortality. We performed a systematic review and included studies that used both UA and in-hospital mortality from Embase and PubMed. Six studies have been included in this review with totally 5,686 patients. During the follow-up, high UA level was found to be associated with an increased risk of in-hospital mortality [risk ratios (RR) 2.10 (1.03–4.26), number needed to harm (NNH) 37], MACE [RR 3.44 (2.33–5.08), NNH 17]. High UA level has the potential to be an important prognostic marker for in-hospital mortality in individuals with AMI.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

References

  1. Kroll, K., Bukowski, T. R., Schwartz, L. M., Knoepfler, D., & Bassingthwaighte, J. B. (1992). Capillary endothelial transport of uric acid in guinea pig heart. American Journal of Physiology, 262, H420–H431.

    CAS  PubMed Central  PubMed  Google Scholar 

  2. Castelli, P., Condemi, A. M., Brambillasca, C., Fundarò, P., Botta, M., Lemma, M., et al. (1995). Improvement of cardiac function by allopurinol in patients undergoing cardiac surgery. Journal of Cardiovascular Pharmacology, 25, 119–125.

    CAS  PubMed  Article  Google Scholar 

  3. Kogure, K., Ishizaki, M., Nemoto, M., Kuwano, H., Tatemoto, K., Maruyama, Y., et al. (1999). Evaluation of serum uric acid changes in different forms of hepatic vascular inflow occlusion in human liver surgeries. Life Sciences, 64, 305–313.

    CAS  PubMed  Article  Google Scholar 

  4. Lazzeri, C., Valente, S., Chiostri, M., Sori, A., Bernardo, P., & Gensini, G. F. (2010). Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: Its prognostic role and relation with inflammatory markers: a single center experience. International Journal of Cardiology, 21(138), 206–209.

    Article  Google Scholar 

  5. Kowalczyk, J., Francuz, P., Swoboda, R., Lenarczyk, R., Sredniawa, B., Golda, A., et al. (2010). Prognostic significance of hyperuricemia in patients with different types of renal dysfunction and acute myocardial infarction treated with percutaneous coronary intervention. Nephron Clinical Practice, 116, c114–c122.

    PubMed  Article  Google Scholar 

  6. Park, S. H., Shin, W. Y., Lee, E. Y., Gil, H. W., Lee, S. W., Lee, S. J., et al. (2011). The impact of hyperuricemia on in-hospital mortality and incidence of acute kidney injury in patients undergoing percutaneous coronary intervention. Circulation Journal, 75, 692–697.

    PubMed  Article  Google Scholar 

  7. Nadkar, M. Y., & Jain, V. I. (2008). Serum uric acid in acute myocardial infarction. Journal of the Association of Physicians of India, 56, 759–762.

    CAS  PubMed  Google Scholar 

  8. Car, S., & Trkulja, V. (2009). Higher serum uric acid on admission is associated with higher short-term mortality and poorer long-term survival after myocardial infarction: Retrospective prognostic study. Croatian Medical Journal, 50, 559–566.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  9. Spoon, D. B., Lerman, A., Rule, A. D., Prasad, A., Lennon, R. J., Holmes, D. R., et al. (2010). The association of serum uric acid levels with outcomes following percutaneous coronary intervention. Journal of Interventional Cardiology, 23, 277–283.

    PubMed  Article  Google Scholar 

  10. Basar, N., Sen, N., Ozcan, F., Erden, G., Kanat, S., Sokmen, E., et al. (2011). Elevated serum uric acid predicts angiographic impaired reperfusion and 1-year mortality in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention. Journal of Investigative Medicine, 59, 931–937.

    CAS  PubMed  Google Scholar 

  11. Kaya, M. G., Uyarel, H., Akpek, M., Kalay, N., Ergelen, M., Ayhan, E., et al. (2012). Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. American Journal of Cardiology, 15(109), 486–491. Epub 2011 Nov 17.

    Article  Google Scholar 

  12. Lazzeri, C., Valente, S., Chiostri, M., Picariello, C., & Gensini, G. F. (2012). Uric acid in the early risk stratification of ST-elevation myocardial infarction. Internal and Emergency Medicine, 7, 33–39. Epub 2011 Jan 15.

    PubMed  Article  Google Scholar 

  13. Glantzounis, G. K., Tsimoyiannis, E. C., Kappas, A. M., & Galaris, D. A. (2005). Uric acid and oxidative stress. Current Pharmaceutical Design, 11, 4145–4151.

    CAS  PubMed  Article  Google Scholar 

  14. Zweier, J. L., Kuppusamy, P., & Lutty, G. A. (1988). Measurement of endothelial cell free radical generation: evidence for a central mechanisms of free radical injury in post ischemic tissue. Proceedings of the National Academy of Sciences, 85, 4046–4050.

    CAS  Article  Google Scholar 

  15. Hare, J. M., & Johnson, R. J. (2003). Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology. Circulation, 107, 1951–1953.

    PubMed  Article  Google Scholar 

  16. Bickel, C., Rupprecht, H. J., Blankenberg, S., Rippin, G., Hafner, G., Daunhauer, A., et al. (2002). Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. American Journal of Cardiology, 89, 12–17.

    CAS  PubMed  Article  Google Scholar 

  17. Bos, M. J., Koudstaal, P. J., Hofman, A., Witteman, J. C., & Breteler, M. M. (2006). Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke, 37, 1503–1507.

    CAS  PubMed  Article  Google Scholar 

  18. Niskanen, L. K., Laaksonen, D. E., Nyyssönen, K., Alfthan, G., Lakka, H. M., Lakka, T. A., et al. (2004). Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: A prospective cohort study. Archives of Internal Medicine, 164, 1546–1551.

    CAS  PubMed  Article  Google Scholar 

  19. Festa, A., & Haffner, S. M. (2005). Inflammation and cardiovascular disease in patients with diabetes: Lessons from the diabetes control and complications trial. Circulation, 11, 2414–2415.

    Article  Google Scholar 

  20. Kojima, S., Sakamoto, T., Ishihara, M., Kimura, K., Miyazaki, S., Yamagishi, M., et al. (2005). Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study). American Journal of Cardiology, 15(96), 489–495.

    Article  Google Scholar 

  21. Schweiger, M. J., Cannon, C. P., Murphy, S. A., Gibson, C. M., Cook, J. R., Giugliano, R. P., et al. (2001). Early coronary intervention following pharmacologic therapy for acute myocardial infarction (the combined TIMI 10B-TIMI 14 experience). American Journal of Cardiology, 88, 831–836.

    CAS  PubMed  Article  Google Scholar 

  22. Yildiz, A., Yilmaz, R., Demirbag, R., Gur, M., Bas, M. M., & Erel, O. (2007). Association of serum uric acid level and coronary blood flow. Coronary Artery Disease, 18, 607–613.

    PubMed  Article  Google Scholar 

  23. Morishima, I., Sone, T., Mokuno, S., Taga, S., Shimauchi, A., Oki, Y., et al. (1995). Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplasty. American Heart Journal, 130, 239–243.

    CAS  PubMed  Article  Google Scholar 

  24. Morishima, I., Sone, T., Okumura, K., Tsuboi, H., Kondo, J., Mukawa, H., et al. (2000). Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. Journal of the American College of Cardiology, 36, 1202–1209.

    CAS  PubMed  Article  Google Scholar 

  25. Ito, H., Maruyama, A., Iwakura, K., Takiuchi, S., Masuyama, T., Hori, M., et al. (1996). Clinical implications of the ‘no reflow’ phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation, 93, 223–228.

    CAS  PubMed  Article  Google Scholar 

  26. Iliceto, S., Galiuto, L., Marchese, A., Colonna, P., Oliva, S., & Rizzon, P. (1997). Functional role of microvascular integrity in patients with infarct-related artery patency after acute myocardial infarction. European Heart Journal, 18, 618–624.

    CAS  PubMed  Article  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Zonghong Liu.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yan, L., Liu, Z. & Zhang, C. Uric Acid as a Predictor of In-Hospital Mortality in Acute Myocardial Infarction: A Meta-analysis. Cell Biochem Biophys 70, 1597–1601 (2014). https://doi.org/10.1007/s12013-014-0101-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-014-0101-7

Keywords

  • Uric acid
  • In-hospital mortality
  • Acute myocardial infarction